Lacosamide is an anti-seizure medication used to treat epilepsy. It is FDA-approved for partial-onset seizures (also called focal seizures) in patients as young as 1 month old, and for primary generalized tonic-clonic seizures in patients 4 years and older. Sold under the brand name Vimpat, it can be prescribed on its own or alongside other seizure medications.
Types of Seizures It Treats
Lacosamide’s primary use is for partial-onset seizures, the most common seizure type in adults with epilepsy. These seizures start in one area of the brain and may or may not spread to both sides. They can cause involuntary movements, altered awareness, or unusual sensations depending on where in the brain they originate. Lacosamide can be used either as the sole treatment or added to another seizure medication that isn’t providing full control.
It is also approved as add-on therapy for primary generalized tonic-clonic seizures, the type most people picture when they think of epilepsy: loss of consciousness, body stiffening, and rhythmic jerking. This indication applies to patients 4 years of age and older.
How It Works in the Brain
Like several other seizure medications, lacosamide acts on sodium channels, the tiny gates in nerve cells that control electrical signaling. But it works in a way no other seizure drug does. Most sodium-channel-blocking medications interfere with what’s called “fast inactivation,” essentially hitting the brakes on nerve firing over milliseconds. Lacosamide instead targets “slow inactivation,” a process that unfolds over seconds. It increases the number of sodium channels that enter this longer resting state and makes them do so more readily.
The practical result is that lacosamide calms neurons that are firing abnormally for sustained periods, the kind of runaway electrical activity that produces seizures, without dramatically disrupting normal brain signaling. This unique mechanism is one reason lacosamide can be effective for people who haven’t responded well to older medications.
Available Forms and Typical Dosing
Lacosamide comes as a tablet, an oral solution, an extended-release capsule (Motpoly XR), and an intravenous formulation for use in hospitals when a patient temporarily can’t take medication by mouth. The IV version is absorbed at levels equivalent to the oral tablet, so switching between the two doesn’t require dose adjustments.
For adults using it as add-on therapy, the usual starting dose is 50 mg twice daily. This is increased weekly in increments of 50 mg twice daily until reaching a maintenance dose of 100 to 200 mg twice daily (200 to 400 mg per day total). The gradual ramp-up helps minimize side effects. For people with significant kidney or liver problems, a lower maximum of 300 mg per day is recommended, and it’s generally avoided entirely in severe liver disease.
Common Side Effects
The most frequently reported side effects are dizziness, headache, nausea, and double vision. These tend to be dose-related, meaning they’re more likely at higher doses and often improve as your body adjusts or if the dose is reduced. Coordination problems and drowsiness can also occur, particularly early in treatment or after a dose increase.
One side effect worth knowing about involves the heart. Lacosamide can slow electrical conduction through the heart, specifically lengthening what’s called the PR interval on an EKG. For most people this is clinically insignificant, but it matters if you already have a heart conduction problem, structural heart disease, or are taking other medications that affect heart rhythm. In those cases, your doctor will likely order an EKG before starting lacosamide and again once you’ve reached a stable dose.
Like all seizure medications, lacosamide carries a small increased risk of suicidal thoughts or mood changes. This is a class-wide warning that applies to every anti-seizure drug, not something unique to lacosamide, but it’s important to be aware of new or worsening depression or unusual mood shifts after starting treatment.
Interactions With Other Medications
One of lacosamide’s practical advantages is that it plays well with other drugs. It does not significantly alter blood levels of common seizure medications including valproic acid, carbamazepine, lamotrigine, levetiracetam, topiramate, phenytoin, or gabapentin. This makes it easier to add to an existing medication regimen without disrupting the balance.
The interaction works both ways for the most part. Valproic acid and carbamazepine don’t meaningfully change lacosamide levels. However, some older enzyme-inducing seizure drugs like carbamazepine, phenobarbital, and phenytoin can reduce lacosamide concentrations by 15% to 20%, which your prescriber may account for with a slight dose adjustment. People with kidney or liver impairment who also take strong enzyme inhibitors may see higher-than-expected lacosamide levels, so closer monitoring is appropriate in that situation.
Use in Emergency Seizure Situations
Although not its primary FDA indication, intravenous lacosamide is increasingly used in hospitals for refractory status epilepticus, a dangerous condition in which seizures persist despite first-line treatments. Early clinical experience has shown resolution of non-convulsive status epilepticus in roughly 70% of cases treated with IV lacosamide, though this data comes from small case series rather than large controlled trials. It is typically tried after standard emergency treatments have failed.